EMVISION MEDICAL DEVICES LIMITED (EMV)
Share Price Analysis and Chart
Enter the company code or Name for stock analysis:

EMV - EMVISION MEDICAL DEVICES LIMITED
FNArena Sector : Medical Equipment & Devices
Year End: June
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: -0.07
Index:
LAST PRICE | CHANGE +/- | CHANGE % | VOLUME |
---|---|---|---|
$1.52
06 Dec |
OPEN $1.50 |
HIGH $1.58 |
15,783 LOW $1.50 |
OTHER COMPANIES IN THE SAME SECTOR | |||
4DX . AT1 . BRN . CAT . CBL . CGS . CMP . COH . CSX . CU6 . CYC . EBR . EYE . FPH . HLA . IDX . IME . IMR . IPD . LDX . MX1 . NAN . ONE . PCK . PEB . PGC . PME . RMD . SOM . TRJ . UBI . VHT . VTI . |
FNARENA'S MARKET CONSENSUS FORECASTS
- No Record -
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2023 FactSet UK Limited. All rights reserved
Title | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EPS Basic | xxx | xxx | xxx | xxx | -5.0 |
DPS All | xxx | xxx | xxx | xxx | 0.0 |
Sales/Revenue | xxx | xxx | xxx | xxx | - |
Book Value Per Share | xxx | xxx | xxx | xxx | 6.6 |
Net Operating Cash Flow | xxx | xxx | xxx | xxx | 0.8 M |
Net Profit Margin | xxx | xxx | xxx | xxx | - |
EPS Basic
DPS All
Sales/Revenue
Book Value Per Share
Net Operating Cash Flow
Net Profit Margin
Title | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Return on Capital Employed | xxx | xxx | xxx | xxx | -63.47 % |
Return on Invested Capital | xxx | xxx | xxx | xxx | -59.32 % |
Return on Assets | xxx | xxx | xxx | xxx | -38.66 % |
Return on Equity | xxx | xxx | xxx | xxx | -63.47 % |
Return on Total Capital | xxx | xxx | xxx | xxx | -136.81 % |
Free Cash Flow ex dividends | xxx | xxx | xxx | xxx | 0.6 M |
Return on Capital Employed
Return on Invested Capital
Return on Assets
Return on Equity
Return on Total Capital
Free Cash Flow ex dividends
Title | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Short-Term Debt | xxx | xxx | xxx | xxx | 3 M |
Long Term Debt | xxx | xxx | xxx | xxx | 0 M |
Total Debt | xxx | xxx | xxx | xxx | 3 M |
Goodwill - Gross | xxx | xxx | xxx | xxx | - |
Cash & Equivalents - Generic | xxx | xxx | xxx | xxx | 10 M |
Price To Book Value | xxx | xxx | xxx | xxx | 17.82 |
Short-Term Debt
Long Term Debt
Total Debt
Goodwill - Gross
Cash & Equivalents - Generic
Price To Book Value
Title | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Capex | xxx | xxx | xxx | xxx | 0.2 M |
Capex % of Sales | xxx | xxx | xxx | xxx | - |
Cost of Goods Sold | xxx | xxx | xxx | xxx | 0 M |
Selling, General & Admin. Exp & Other | xxx | xxx | xxx | xxx | 11 M |
Research & Development | xxx | xxx | xxx | xxx | 2 M |
Investments - Total | xxx | xxx | xxx | xxx | - |
Capex
Capex % of Sales
Cost of Goods Sold
Selling, General & Admin. Exp & Other
Research & Development
Investments - Total
EXPERT VIEWS
Display All Commentary
Sentiment Indicator
No. Of Recommendations
EMV STOCK CHART

FNArena News on EMV
1 |
Dr Boreham’s Crucible: Argenica TherapeuticsSep 28 2023 - Small Caps |
2 |
Australian Broker Call *Extra* Edition – Feb 06, 2023Feb 06 2023 - Daily Market Reports |
3 |
Australian Broker Call *Extra* Edition – Nov 16, 2022Nov 16 2022 - Daily Market Reports |
4 |
Who Will Be The Next Pro Medicus?May 13 2021 - Weekly Reports |
5 |
Rudi’s View: Osteopore, Whitehaven Coal and TelstraDec 06 2019 - Rudi's View |
Latest Medical Equipment & Devices News
1 |
Dr Boreham’s Crucible: Pro MedicusOct 23 2023 - Australia |
2 |
Dr Boreham’s Crucible: CyclopharmOct 09 2023 - Small Caps |
3 |
Dr Boreham’s Crucible: PainchekSep 11 2023 - Small Caps |
4 |
Margins Signal Integral Diagnostics RecoverySep 07 2023 - Australia |
5 |
ResMed: Finding A Base?Aug 15 2023 - Technicals |
6 |
August Turns ResMed Into Nigel NoMatesAug 09 2023 - Australia |
7 |
Dr Boreham’s Crucible: Lumos DiagnosticsJun 19 2023 - Small Caps |
8 |
Fisher & Paykel Healthcare: Lower Margin, Higher SpendingMay 30 2023 - Australia |
9 |
Dr Boreham’s Crucible: ImpedimedMay 08 2023 - Small Caps |
10 |
Treasure Chest: ResMed’s Benevolent MonopolyMay 01 2023 - Treasure Chest |